Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May-Jun;21(3):260-7.
doi: 10.1111/tbj.12392. Epub 2015 Mar 19.

Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers

Soley Bayraktar  1 , Michelle Jackson, Angelica M Gutierrez-Barrera, Diane Liu, Funda Meric-Bernstam, Amanda Brandt, Ashley Woodson, Jennifer Litton, Karen H Lu, Vicente Valero, Banu K Arun
Affiliations

Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers

Soley Bayraktar et al. Breast J. 2015 May-Jun.

Abstract

The genotype-phenotype correlations of the specific BRCA1 and BRCA2 mutations in multi-ethnic populations in USA have not yet been fully investigated. This study was designed to evaluate the effects of ethnicity at specific mutation locations and breast/ovarian cancer phenotypes. Our cohort included 445 women with different ethnic backgrounds who underwent BRCA genetic testing between 1997 and 2010. Known clinical and pathologic characteristics were compared with Chi-Square Analysis or Fisher's Exact test as appropriate. The three most common mutation locations in BRCA1 (exons 2, 11, and 20) and BRCA2 (exons 10, 11, and 25) genes were chosen. Prevalence of BRCA1 exon 2 mutations were significantly higher in Ashkenazi Jewish (AJ) women compared to Caucasians (41% versus 15%; p = 0.001). Similarly, AJ women with breast cancer were more likely to have BRCA1 exon 2 mutation (47% positivity in AJ women versus 0-12.5% positivity in other ethnicities; p = 0.004). Women carrying the exon 20 BRCA1 mutation had the highest probability of having combined breast and ovarian cancers compared to women carrying other exon mutations (p = 0.05). The median age at initial cancer diagnosis, phenotypic features of breast cancer tumors, and overall survival did not vary significantly by ethnicity or mutation location. Our data suggest that ethnicity does not affect age of onset, overall survival or confer different risks of breast and ovarian cancer development in BRCA carriers. These results also suggest that women carrying the exon 20 BRCA1 mutation may warrant mutation-specific counseling and be more aggressively managed for risk reduction.

Keywords: BRCA1; BRCA2; breast cancer; ethnicity; mutation location; ovarian cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ethnicities represented in the study population
Figure 2
Figure 2
Kaplan–Meier estimates of overall survival (OS) by BRCA mutation location for BRCA1 carriers (2A); for BRCA2 carriers (2B).
Figure 3
Figure 3
Kaplan–Meier estimates of overall survival (OS) by three combined exon groups for BRCA1 carriers (3A); for BRCA2 carriers (3B).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet. 1997;60(5):1013–20. - PMC - PubMed
    1. Rebbeck TR, Domchek SM. Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2008;10:108. - PMC - PubMed
    1. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98:1694–706. - PubMed
    1. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643–6. - PubMed
    1. Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res. 2006;66(16):8297–308. - PubMed

Publication types